Arama Sonuçları - Samar Issa
- Gösterilen 1 - 11 sonuçlar arası kayıtlar. 11
-
1
Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma Yazar: Maurilio Ponzoni, Samar Issa, Tracy T. Batchelor, James L. Rubenstein
Baskı/Yayın Bilgisi 2013Revisão -
2
Regulation of microRNAs in cancer metastasis Yazar: Juliette Bouyssou, Salomon Manier, Daisy Huynh, Samar Issa, Aldo M. Roccaro, Irene M. Ghobrial
Baskı/Yayın Bilgisi 2014Revisão -
3
Carbazole scaffolds in cancer therapy: a review from 2012 to 2018 Yazar: Samar Issa, Anthony Prandina, Nicolas Bedel, Pål Rongved, Saı̈d Yous, Marc Le Borgne, Zouhair Bouaziz
Baskı/Yayın Bilgisi 2019Revisão -
4
Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation - an International Primary Central Nervous System Lymphoma Study Group project Yazar: Jacoline E. C. Bromberg, Jeanette K. Doorduijn, Gerald Illerhaus, Kristoph Jahnke, Agnieszka Korfel, L. Fischer, Kristina Fritsch, Outi Kuittinen, Samar Issa, C. van Montfort, Martin J. van den Bent
Baskı/Yayın Bilgisi 2012Artigo -
5
Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI Yazar: Matthew J. Wieduwilt, Francisco Valles, Samar Issa, Caroline Behler, James Q. Hwang, Michael McDermott, Patrick Treseler, Joan M. O’Brien, Marc A. Shuman, Soonmee Cha, Lloyd E. Damon, James L. Rubenstein
Baskı/Yayın Bilgisi 2012Artigo -
6
Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma Yazar: James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey, Arthur Shen, Jon Karch, Endi Wang, Samar Issa, Lloyd E. Damon, Michael D. Prados, Michael McDermott, Joan M. O’Brien, Chris Haqq, Marc Shuman
Baskı/Yayın Bilgisi 2007Artigo -
7
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Fo... Yazar: Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, David Simpson, Kathryn S. Kolibaba, Samar Issa, Julie Chang, Judith Trotman, Doreen M. Hallman, Ling Chen, John M. Burke
Baskı/Yayın Bilgisi 2019Artigo -
8
Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience Yazar: Katharine L. Lewis, Collin K. Chin, Kate Manos, John Casey, Nada Hamad, Julie Crawford, Shir‐Jing Ho, Samar Issa, Andrew Grigg, Peter Wood, Maher K. Gandhi, Bryan Do, Loretta J. Nastoupil, Eliza A. Hawkes, Chan Y. Cheah
Baskı/Yayın Bilgisi 2020Artigo -
9
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Yazar: Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, Mark Hertzberg, Yiu‐Lam Kwan, David Simpson, Michael Craig, Kathryn S. Kolibaba, Samar Issa, Regina Clementi, Doreen M. Hallman, Mihaela Munteanu, Ling Chen, John M. Burke
Baskı/Yayın Bilgisi 2014Artigo -
10
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study Yazar: Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chávez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon
Baskı/Yayın Bilgisi 2018Artigo -
11
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets Yazar: David T Yeung, Michael Osborn, Deborah L. White, Susan Branford, Jodi Braley, Alan Herschtal, Michael Kornhauser, Samar Issa, Devendra Hiwase, Mark Hertzberg, Anthony P. Schwarer, Robin Filshie, Christopher Arthur, Yiu Lam Kwan, Judith Trotman, Cecily Forsyth, John Taper, David M. Ross, J. Beresford, Constantine S. Tam, Anthony K. Mills, Andrew Grigg, Timothy P. Hughes
Baskı/Yayın Bilgisi 2014Artigo
Arama Araçları:
İlgili Konular
Internal medicine
Medicine
Lymphoma
Oncology
Rituximab
Chemotherapy
Primary central nervous system lymphoma
Surgery
Biology
Astrobiology
Bendamustine
Bioinformatics
CHOP
Cancer
Cancer research
Chronic lymphocytic leukemia
Clinical trial
Gastroenterology
Genetics
Ibrutinib
Leukemia
Physics
Refractory (planetary science)
Antibody
Autologous stem-cell transplantation
B cell
BCL6
Biochemistry
Cancer cell
Cancer therapy